论文部分内容阅读
目的和方法为观察新正天丸组治疗儿童偏头痛的临床疗效，我们将61例儿童偏头痛随机分为二组，分别给予新正无丸（6g/次，每日3次，口服）和尼莫地平（20my次，每日3次，口服）治疗，其中新正天丸组32例，尼莫地平组29例。结果新正天丸组基本恢复率为40．62％，显效率为43．75％，总有效率为93．75％：尼莫地平组基本恢复率为10．34％，显效率为20．69％，总有效率为79．30％，两组比较有显著性差异（P＜0．01）。结论新正天丸在治疗儿童偏头痛方面有较好疗效，可能优于尼莫地平。
Objectives and Methods To observe the clinical efficacy of Xinzheng pill in the treatment of migraine in children, we randomly assigned 61 children with migraine to two groups: Xinzheng Pill (6g / time, 3 times daily, orally) and Nimodipine (20my times, 3 times a day, orally) treatment, including 32 cases of Xinzhengtian pill, nimodipine group 29 cases. Results The recovery rate of Xinzhengtian pill group was 40.62%, the effective rate was 43.75%, the total effective rate was 93.75%. The basic recovery rate was 10.34% in nimodipine group and the effective rate was 20. 69%, the total effective rate was 79.30%, there was a significant difference between the two groups (P <0.01). Conclusion Xinzheng pill in the treatment of children with migraine has a good effect, may be superior to nimodipine.